Carrie C Lubitz
Affiliation: Massachusetts General Hospital
- Clinical and cytological features predictive of malignancy in thyroid follicular neoplasmsCarrie C Lubitz
Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Thyroid 20:25-31. 2010..The aim of this study was to determine predictive characteristics of follicular neoplasms useful for clinical application...
- Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidismCarrie C Lubitz
Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
Surgery 148:1129-37; discussion 1137-8. 2010..We assessed the role of 4D-CT in patients with inconclusive preoperative ultrasound and sestamibi localization studies...
- Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid CarcinomaCarrie C Lubitz
Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts Electronic address
J Mol Diagn 18:100-8. 2016..This blood assay is feasible and has potential as a biomarker for prognosis, surveillance, clinical decision making, and assessment of treatment response to BRAF-targeted therapies. ..
- Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive PatientsCarrie C Lubitz
From the Departments of Surgery C C L, K P E and Radiology G S G, Massachusetts General Hospital, Boston Department of Radiology, Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA C C L, K P E, C J, G S G Department of Health Policy and Management, Harvard T H Chan School of Public Health, Boston, MA S S, G S G, M C W, T A G Schwerpunkt Endokrinologie, Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig Maximilians Universität München, Munchen, Germany H E K, M R and Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women s Hospital, Boston, MA T A G
Circ Cardiovasc Qual Outcomes 8:621-30. 2015..We aim to assess if the long-term cardiovascular benefits of identifying and treating surgically correctable PA outweigh the upfront increased costs in patients at the time patients are diagnosed with resistant hypertension (RH)...
- Preoperative localization strategies for primary hyperparathyroidism: an economic analysisCarrie C Lubitz
Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Ann Surg Oncol 19:4202-9. 2012..Strategies for localizing parathyroid pathology preoperatively vary in cost and accuracy. Our purpose was to compute and compare comprehensive costs associated with common localization strategies...
- Diagnostic yield of nondiagnostic thyroid nodules is not altered by timing of repeat biopsyCarrie C Lubitz
Department of Surgery Endocrine Surgery Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Thyroid 22:590-4. 2012..Our aims were to assess which factors influenced their clinical management and to determine if the timing of the repeat FNAB affects the diagnostic yield...
- Surgery for Graves' disease: a 25-year perspectiveRoy Phitayakorn
Thyroid Cancer Research Laboratory, Endocrine Surgery Unit, The Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, Wang ACC 460, Boston, MA 02115, USA
Am J Surg 206:669-73. 2013..Optimal treatment of Graves' disease (GD) remains controversial. The authors retrospectively reviewed the surgical cases of GD at a single academic tertiary center...
- BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrenceJason D Prescott
Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 2696, USA
Surgery 152:984-90. 2012..No current risk classification system incorporates BRAF mutational status. Here, we assess the incremental value of BRAF mutational status in predicting PTC recurrence relative to existing recurrence risk algorithms...
- Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsySushruta S Nagarkatti
Thyroid Cancer Laboratory, Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Ann Surg Oncol 20:60-5. 2013..We sought to assess the characteristics and treatment of patients with an AUS/FLUS FNAB at our institution. Additionally, we evaluated the utility of the recommended 3-month timing of repeat FNAB...
- Identification of borderline thyroid tumors by gene expression array analysisNimmi Arora
Department of Surgery, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York 10065, USA
Cancer 115:5421-31. 2009..A subset of follicular lesions of the thyroid is encapsulated similar to follicular adenomas but with partial nuclear features suggestive of papillary thyroid carcinoma (PTC), raising the possibility of biologically borderline tumors...
- BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-AnalysisYufei Chen
1 Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts
Thyroid 26:248-55. 2016..The BRAF(V600E) mutation has been associated with recurrent disease in larger tumors. However, its correlation in papillary thyroid microcarcinoma (PTMC) is not clear in individual series...
- Annual financial impact of well-differentiated thyroid cancer care in the United StatesCarrie C Lubitz
Harvard Medical School, Boston, Massachusetts Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts
Cancer 120:1345-52. 2014..Prior analyses of the aggregate health care costs attributable to WDTC in the United States have not been reported...
- Recalcitrant hypocalcemia after thyroidectomy in patients with previous Roux-en-Y gastric bypassTravis J McKenzie
Massachusetts General Hospital, Department of Surgery, Wang Ambulatory Care Center, Boston, MA Electronic address
Surgery 154:1300-6; discussion 1306. 2013..This complication is poorly described and there is no current consensus on optimal management in this unique population...
- Surgical drains can be safely avoided in lateral neck dissections for papillary thyroid cancerMichal Mekel
Endocrine Surgery Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Am J Surg 199:485-90. 2010..Drains are widely used in lateral neck dissections (LNDs). Our objective was to compare outcomes of LNDs for papillary thyroid cancer (PTC) with and without drains...
- Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinomaDana T Yip
Departments of Surgery, Pathology, and Thyroid Unit, Massachusetts General Hospital, Boston, MA 02114, USA
Surgery 150:1168-77. 2011..We hypothesized that preoperative serum levels of calcitonin and carcinoembryonic antigen (CEA) correlate with extent of disease and postoperative levels reflect the extent of operation performed...
- Molecular analysis of minimally invasive follicular carcinomas by gene profilingCarrie C Lubitz
Department of Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
Surgery 138:1042-8; discussion 1048-9. 2005..These studies were conducted to determine if molecular profiling can enhance our understanding of MIFTC and to perhaps offer a better classification schema...
- The Truth about Double Adenomas: Incidence, Localization, and Intraoperative Parathyroid HormoneLucia De Gregorio
Department of Surgery, Massachusetts General Hospital, Boston, MA
J Am Coll Surg 222:1044-52. 2016..The aim of this study was to determine the true incidence of double adenoma and analyze the use of localization studies and intraoperative parathyroid hormone (IOTPH) assay in these cases...
- Should specific patient clinical characteristics discourage adrenal surgeons from performing laparoscopic transperitoneal adrenalectomy?Konstantinos P Economopoulos
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Surgery 159:240-8. 2016..We sought to determine whether LTA in these clinical situations is associated with worse outcomes...
- Primary hyperparathyroidism after Roux-en-Y gastric bypassYufei Chen
Massachusetts General Hospital, GRB 425, 55 Fruit Street, Boston, MA, 02114, USA
Obes Surg 25:700-4. 2015..The diagnosis can be difficult, as secondary hyperparathyroidism (SHPT) commonly occurs in patients after RYGBP due to calcium malabsorption and vitamin D deficiency...
- Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesionsCarrie C Lubitz
Department of Surgery, Weill Cornell Medical College, Room A 983, 510 East 70th St, New York, NY 10021, USA
J Mol Diagn 8:490-8; quiz 528. 2006..These results illustrate that microarray analysis of FNA is feasible and has the potential to improve the accuracy of FNA in categorizing benign from malignant lesions beyond routine cytological evaluation...
- The differentiation of benign and malignant thyroid nodulesCarrie C Lubitz
Department of Surgery, New York Presbyterian Hospital, USA
Adv Surg 39:355-77. 2005
- Gene expression profiling of thyroid tumors--clinical applicabilityCarrie C Lubitz
Department of Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
Nat Clin Pract Endocrinol Metab 2:472-3. 2006
- Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid CarcinomaCarrie C Lubitz
1 Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Thyroid . 2016..We assessed which of four well-validated, preference-based surveys detect changes in health and clinical intervention in patients diagnosed with papillary thyroid cancer (PTC)...
- Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profileCarrie C Lubitz
1 Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Thyroid 24:958-65. 2014..Herein, we describe the clinical course, pathologic features, and mutational profile of patients at our institution with HVPTC...
- How to interpret thyroid fine-needle aspiration biopsy reports: a guide for the busy radiologist in the era of the Bethesda Classification SystemManish Dhyani
1 Department of Radiology, Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, White 270, Boston, MA 02114
AJR Am J Roentgenol 201:1335-9. 2013..This article reviews the Bethesda System, emphasizing the key facts necessary to understand thyroid biopsy results and effectively manage patients after FNAB...
- Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profilingDavid J Finley
Department of Surgery, Weill Medical College of Cornell University, New York, New York, USA
Thyroid 15:562-8. 2005..These studies were undertaken to determine whether benign follicular tumors could be subcategorized by molecular profiling...
- Surgeons and patients disagree on the potential consequences from hypoparathyroidismNancy L Cho
Department of Surgery, Brigham and Women s Hospital, Boston, Massachusetts
Endocr Pract 20:427-46. 2014..To test the hypothesis that surgeons and their patients underestimate the potential negative impact that permanent hypoparathyroidism has on quality of life (QOL)...